Interleukin-18 (Mural Oncology)
N/A
Report date: 2024/10/10 10:04:55
Base Information
Drug NameInterleukin-18 (Mural Oncology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A